Artrya Limited (ASX:AYA)

Market Cap	520.10M +615.1%
Revenue (ttm)	1.71M
Net Income	-19.71M
EPS	-0.17
Shares Out	158.08M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	238,186
Average Volume	478,377
Open	3.250
Previous Close	3.290
Day's Range	3.040 - 3.500
52-Week Range	0.560 - 5.240
Beta	0.55
RSI	38.79
Earnings Date	Feb 1, 2026

About Artrya

Artrya Limited, a medical technology company, engages in the development and commercialization of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a suite ifcloud-based software that uses artificial intelligence to automate the detection of coronary artery disease from coronary computed tomography angiography scans to identify and manage patients at risk of a heart attack. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia.

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 2018
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: AYA